BOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announcedBOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced

Charles River Associates (CRA) Strengthens Antitrust Practice with Addition of Former DOJ Division Leader

2026/01/29 21:35
4 min read

BOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Margaret (Peggy) Loudermilk has joined the firm as a Vice President in the Antitrust & Competition Economics Practice. Peggy joins CRA from the U.S. Department of Justice’s (DOJ) Antitrust Division, where she held the position of Assistant Chief of the Economic Regulatory Section.

“We are pleased to welcome Peggy to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “Peggy brings more than two decades of experience in antitrust economics and regulatory analysis. Her background will be a tremendous asset to our team as we continue to strengthen our capabilities in resolving complex competition matters.”

“During her tenure at the DOJ, Peggy was instrumental in high-profile civil and criminal matters, including mergers, conduct investigations, and cartel cases,” said Margaret Sanderson, Vice President and Global Practice Leader of the Antitrust & Competition Economics Practice at CRA. “As antitrust enforcement evolves across jurisdictions, Peggy’s experience is a great asset to our clients to understand current regulatory expectations and develop effective compliance strategies.”

Dr. Loudermilk joins Dr. Nate Goldstein (former DOJ) and Dr. Alison Hole (former FTC), expanding the practice’s roster of former senior agency economists. Their combined experience spans current areas of regulatory focus in mergers and antitrust litigation, including addressing competition in digital markets, horizontal and vertical theories of harm, and multi-jurisdictional coordination between U.S. and international agencies.

Prior to serving as Assistant Chief, Dr. Loudermilk was an Economist in the DOJ’s Antitrust Division, where she performed in-depth economic analysis and developed case recommendations for senior DOJ leadership on numerous merger, criminal, and civil non-merger investigations. She also prepared expert witnesses for trial testimony.

Dr. Loudermilk has a BA in Economics from Boston University, an MA in Economics from Duke University, and a PhD in Economics from Michigan State University.

About CRA’s Antitrust & Competition Economics Practice

CRA’s competition economists provide economic analysis and testimony in competition matters around the world. Many have served in government antitrust agencies and are members of premier academic, economic, and law faculties. Their experience extends to many industries, including healthcare, energy, computer hardware/software, retailing, telecommunications, aerospace and defense, entertainment, transportation, natural resources, sports, chemicals, pharmaceuticals, financial services, and consumer products.

About Charles River Associates (CRA)

Charles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedIn, Instagram, and Facebook.

SAFE HARBOR STATEMENT

Statements in this press release concerning the addition of Dr. Margaret Loudermilk and the strengthening of CRA’s Antitrust & Competition Economics Practice, and any future business Dr. Loudermilk may generate for CRA, are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based upon management’s current expectations and are subject to a number of factors and uncertainties. Information contained in these forward-looking statements is inherently uncertain, and actual performance and results may differ materially due to many important factors. Such factors that could cause actual performance or results to differ materially from any forward-looking statements made by CRA include, among others: the failure to generate engagements for us; the potential loss of clients; the demand environment; global economic conditions; foreign exchange rate fluctuations; and intense competition. Additional potential factors that could affect our financial results are included in our periodic filings with the Securities and Exchange Commission, including those under the heading “Risk Factors.” We cannot guarantee any future results, levels of activity, performance, or achievement. We undertake no obligation to update any forward-looking statements after the date of this press release, and we do not intend to do so.

Contacts

Media Relations
CRA International
media@crai.com
416-825-1595

Nicholas Manganaro
Sharon Merrill Advisors
crai@investorrelations.com
617-542-5300

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XRP Buyers Defend Most Major 200-Week Price Average: Can It Be Bottom of 2026?

XRP Buyers Defend Most Major 200-Week Price Average: Can It Be Bottom of 2026?

The post XRP Buyers Defend Most Major 200-Week Price Average: Can It Be Bottom of 2026? appeared on BitcoinEthereumNews.com. XRP has returned to its 200-week moving
Share
BitcoinEthereumNews2026/02/08 19:49
Expert Tags Ethereum’s ERC-8004 Mainnet Launch An “iPhone Moment”, Here’s What It Means

Expert Tags Ethereum’s ERC-8004 Mainnet Launch An “iPhone Moment”, Here’s What It Means

Market analyst says Ethereum is having an “iPhone moment” as it approaches the ERC-8004 mainnet launch.
Share
Coinstats2026/02/08 19:56
Breaking: CME Group Unveils Solana and XRP Options

Breaking: CME Group Unveils Solana and XRP Options

CME Group launches Solana and XRP options, expanding crypto offerings. SEC delays Solana and XRP ETF approvals, market awaits clarity. Strong institutional demand drives CME’s launch of crypto options contracts. In a bold move to broaden its cryptocurrency offerings, CME Group has officially launched options on Solana (SOL) and XRP futures. Available since October 13, 2025, these options will allow traders to hedge and manage exposure to two of the most widely traded digital assets in the market. The new contracts come in both full-size and micro-size formats, with expiration options available daily, monthly, and quarterly, providing flexibility for a diverse range of market participants. This expansion aligns with the rising demand for innovative products in the crypto space. Giovanni Vicioso, CME Group’s Global Head of Cryptocurrency Products, noted that the new options offer increased flexibility for traders, from institutions to active individual investors. The growing liquidity in Solana and XRP futures has made the introduction of these options a timely move to meet the needs of an expanding market. Also Read: Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! Rapid Growth in Solana and XRP Futures Trading CME Group’s decision to roll out options on Solana and XRP futures follows the substantial growth in these futures products. Since the launch of Solana futures in March 2025, more than 540,000 contracts, totaling $22.3 billion in notional value, have been traded. In August 2025, Solana futures set new records, with an average daily volume (ADV) of 9,000 contracts valued at $437.4 million. The average daily open interest (ADOI) hit 12,500 contracts, worth $895 million. Similarly, XRP futures, which launched in May 2025, have seen significant adoption, with over 370,000 contracts traded, totaling $16.2 billion. XRP futures also set records in August 2025, with an ADV of 6,600 contracts valued at $385 million and a record ADOI of 9,300 contracts, worth $942 million. Institutional Demand for Advanced Hedging Tools CME Group’s expansion into options is a direct response to growing institutional interest in sophisticated cryptocurrency products. Roman Makarov from Cumberland Options Trading at DRW highlighted the market demand for more varied crypto products, enabling more advanced risk management strategies. Joshua Lim from FalconX also noted that the new options products meet the increasing need for institutional hedging tools for assets like Solana and XRP, further cementing their role in the digital asset space. The launch of options on Solana and XRP futures marks another step toward the maturation of the cryptocurrency market, providing a broader range of tools for managing digital asset exposure. SEC’s Delay on Solana and XRP ETF Approvals While CME Group expands its offerings, the broader market is also watching the progress of Solana and XRP exchange-traded funds (ETFs). The U.S. Securities and Exchange Commission (SEC) has delayed its decisions on multiple crypto-related ETF filings, including those for Solana and XRP. Despite the delay, analysts anticipate approval may be on the horizon. This week, REX Shares and Osprey Funds are expected to launch an XRP ETF that will hold XRP directly and allocate at least 40% of its assets to other XRP-related ETFs. Despite the delays, some analysts believe that approval could come soon, fueling further interest in these assets. The delay by the SEC has left many crypto investors awaiting clarity, but approval of these ETFs could fuel further momentum in the Solana and XRP futures markets. Also Read: Tether CEO Breaks Silence on $117,000 Bitcoin Price – Market Reacts! The post Breaking: CME Group Unveils Solana and XRP Options appeared first on 36Crypto.
Share
Coinstats2025/09/18 02:35